Journals / Turkish Journal of Medical Sciences / 2019 / Cilt: 49 - Sayı: 5

Protective effect of cyclosporine A in the treatment of severe hydronephrosis in a rabbit renal pelvic perfusion model

Pages
1590–1598
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The cytochrome C (CytC) and neutrophil gelatinase-associated lipocalin (NGAL)expression were examined immunohistochemically using Western blotting and reverse transcription-polymerase chain reaction.Results: It was found that the renal histopathological damage was ameliorated, mitochondrial vacuolization was lower, MMP was higher, and the CytC and NGAL contents were decreased after drug intervention (groups S1’ and S2’) when compared to the experimentalgroups (S1 and S2).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Cyclosporine A (CsA), a traditional immunosuppressive compound, has been reported to specifically prevent ischemia reperfusion tissue injury via apoptosis pathway.
📊
Key Findings & Data:This study aimed to explore the renoprotective effects of CsA on the kidneys ofrabbits undergoing renal pelvic perfusion.Materials and methods: A total of 30 rabbits were randomly assigned into a control group (n = 6) and an experimental group (n = 24).The experimental group underwent a surgical procedure that induced severe hydronephrosis and was then stochastically divided into 4groups (S1, S1’, S2, and S2’), consisting of 6 rabbits each.
💡
Conclusion & Impact:The cytochrome C (CytC) and neutrophil gelatinase-associated lipocalin (NGAL)expression were examined immunohistochemically using Western blotting and reverse transcription-polymerase chain reaction.Results: It was found that the renal histopathological damage was ameliorated, mitochondrial vacuolization was lower, MMP was higher, and the CytC and NGAL contents were decreased after drug intervention (groups S1’ and S2’) when compared to the experimentalgroups (S1 and S2).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: Cyclosporine A (CsA), a traditional immunosuppressive compound, has been reported to specifically prevent ischemia reperfusion tissue injury via apoptosis pathway. This study aimed to explore the renoprotective effects of CsA on the kidneys ofrabbits undergoing renal pelvic perfusion.Materials and methods: A total of 30 rabbits were randomly assigned into a control group (n = 6) and an experimental group (n = 24).The experimental group underwent a surgical procedure that induced severe hydronephrosis and was then stochastically divided into 4groups (S1, S1’, S2, and S2’), consisting of 6 rabbits each. Groups S1 and S1’ were perfused with 20 mmHg of fluid, while groups S2 andS2’ were perfused with 60 mmHg of fluid. Administration to groups S1’ and S2’ was done intravenously, with CsA once a day for 1 weekbefore perfusion. In the control group, after severe hydronephrosis was induced, a sham operation was performed in a second laparotomy. Acute kidney damage was evaluated using hematoxylin and eosin staining, in addition to analyzing the mitochondrial ultrastructureand mitochondrial membrane potential (MMP). The cytochrome C (CytC) and neutrophil gelatinase-associated lipocalin (NGAL)expression were examined immunohistochemically using Western blotting and reverse transcription-polymerase chain reaction.Results: It was found that the renal histopathological damage was ameliorated, mitochondrial vacuolization was lower, MMP was higher, and the CytC and NGAL contents were decreased after drug intervention (groups S1’ and S2’) when compared to the experimentalgroups (S1 and S2). Furthermore, there was no difference between drug intervention groups S1’ and S2’.Conclusion: These results suggest that CsA can attenuate renal damage from severe hydronephrosis induced by renal pelvic perfusionin rabbits. It plays a protective role in the acute kidney injury process, possibly through increased MMP and mitochondrial changes.

🔖

Cite This Article

ZHOU, B. Z., ZHANG, D. H., YU, W. M., NING, J. Z. (2022). Protective effect of cyclosporine A in the treatment of severe hydronephrosis in a rabbit renal pelvic perfusion model. Turkish Journal of Medical Sciences, Cilt: 49 - Sayı: 5, 1590–1598. https://ajindex.com/articles/609983

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Elashry OM, Elgamasy AK, Sabaa MA, Abo-Elenien M, Omar MA et al. Ureteroscopic management of lower ureteric calculi: a 15-year single-centre experience. BJU International 2008; 102 (8): 1010-1017. doi: 10.1111/j.1464-410X.2008.07747.x 2. Nabi G, Downey P, Keeley F, Watson G, McClinton S. Extra-corporeal shock wave lithotripsy (ESWL) versus ureteroscopic management for ureteric calculi. Cochrane Database of Systematic Reviews 2007; 24 (1): CD006029. doi: 10.1002/14651858.CD006029.pub2 3. Wang J, Zhou DQ, He M, Li WG, Pang X et al. Effects of renal pelvic high-pressure perfusion on nephrons in a porcine pyonephrosis model. Experimental and Therapeutic Medicine 2013; 5 (5): 1389-1392. doi: 10.3892/etm.2013.1023 4. Shao Y, Sha M, Chen L, Li D, Lu J et al. HMGB1/TLR4 signaling induces an inflammatory response following high-pressure renal pelvic perfusion in a porcine model. American Journal of Physiology-Renal Physiology 2016; 311 (5): F915-F925. doi: 10.1152/ajprenal.00480.2015 5. Tai CK, Li SK, Fung TC. Measurement of renal intrapelvic pressure during minimally invasive percutaneous nephrolithotomy (MPCNL), using pressurized irrigation of 350 mmHg. European Urology Supplements 2014; 7 (3): 190- 190. doi:10.1016/S1569-9056(08)60474-1 6. Cao Z, Yu W, Li W, Cheng F, Xia Y et al. Acute kidney injuries induced by various irrigation pressures in rat models of mild and severe hydronephrosis. Urology 2013; 82 (6): 1453.e9-e16. doi: 10.1016/j.urology.2013.08.024 7. Alexopoulos P, Panoutsopoulou K, Vogiatzis G, Koletsis E, Dougenis D et al. Combined treatment with exenatide and cyclosporine A or parstatin 1-26 results in enhanced reduction of infarct size in a rabbit model. Journal of Cardiovascular Pharmacology 2017; 70 (1): 34-41. doi: 10.1097/ FJC.0000000000000492 8. Tachibana T, Shiiya N, Kunihara T, Wakamatsu Y, Kudo AF et al. Immunophilin ligands FK506 and cyclosporine A improve neurologic and histopathologic outcome after transient spinal cord ischemia in rabbits. Journal of Thoracic and Cardiovascular Surgery 2005; 129 (1): 123-128. doi: 10.1016/j. jtcvs.2004.04.047 9. Nighoghossian N, Ovize M, Mewton N, Ong E, Cho TH. Cyclosporine A, a potential therapy of ischemic reperfusion injury. A common history for heart and brain. Cerebrovascular Diseases 2016; 42 (5): 309-318. doi: 10.1159/000446850 10. Li J, Yan Z, Fang Q. A mechanism study underlying the protective effects of cyclosporine-A on lung ischemiareperfusion injury. Pharmacology 2017; 100 (1): 83-90. d